51³Ô¹Ïapp
Back to
Dr Claudia Bruno

Dr Claudia Bruno

Research Associate

ÌýPhD in Public Health and Community Medicine, UNSW Sydney 2020-2023
Thesis title: Using real-world data to generate evidence to improve quality use of psychotropic medicines in priority populations.Ìý

Bachelor of Science (Statistics and Physiology major), Honours in Medical Science, UNSW Sydney (2014-2018)
Thesis title:ÌýProton pump inhibitor use in Australia: evaluating national quality use of medicines initiatives.

Medicine & Health
School of Population Health

As a pharmacoepidemiologist, I use population-based data to examine the quality use of psychotropic medicines among priority populations. My research aims to promote best-practice healthcare through public health policy and clinical practice changes.ÌýÌý

I am an early career researcher with the Medicines Intelligence (MedIntel) Research Program at the School of Population Health. Throughout my career, I have conducted extensive analyses of linked health data on both national and international levels. Notably, I participated in a multinational collaboration with the Nordic countries, during an eight-month placement at the Norwegian Public Health Institute in Oslo. This partnership enabled knowledge exchange and provided valuable insights into the safety of medicines in pregnancy and the analysis of multinational data.Ìý

I am passionate about using population-based linked data and sophisticated methods to provide evidence about real-world medicine use and outcomes. I am particularly interested in the safety and quality use of medicines among high-risk and under-served population groups, including pregnant women and children.ÌýÌý
E-mail
c.bruno@unsw.edu.au
  • Journal articles | 2024
    Bruno C; Cesta CE; Hjellvik V; Ulrichsen SP; Bjørk MH; Esen BÖ; Gillies MB; Gissler M; Havard A; Karlstad Ø; Leinonen MK; Nørgaard M; Pearson SA; Reutfors J; Furu K; Cohen JM; Zoega H, 2024, 'Antipsychotic use during pregnancy and risk of specific neurodevelopmental disorders and learning difficulties in children: a multinational cohort study', eClinicalMedicine, 70,
    Journal articles | 2024
    Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson SA, 2024, 'The Medicines Intelligence Data Platform: A Population-Based Data Resource From New South Wales, Australia', Pharmacoepidemiology and Drug Safety, 33,
    Journal articles | 2023
    Bruno C; Havard A; Gillies MB; Coghill D; Brett J; Guastella AJ; Pearson SA; Zoega H, 2023, 'Patterns of attention deficit hyperactivity disorder medicine use in the era of new non-stimulant medicines: A population-based study among Australian children and adults (2013–2020)', Australian and New Zealand Journal of Psychiatry, 57, pp. 675 - 685,
    Journal articles | 2023
    Bruno C; Zoega H; Gillies MB; Havard A; Coghill D; Pearson SA; Brett J, 2023, 'Expanded access to publicly subsidised lisdexamfetamine treatment for adults with attention-deficit/hyperactivity disorder: An interrupted time-series analysis', Australian and New Zealand Journal of Psychiatry, 57, pp. 1073 - 1076,
    Journal articles | 2022
    Bruno C; Havard A; Hanly M; Falster K; Nassar N; Edwards B; Guastella AJ; Pearson SA; Zoega H, 2022, 'Children's Relative Age and Medicine Treatment for Attention-Deficit/Hyperactivity Disorder Across Australian Jurisdictions with Different School Enrolment Policies', Journal of Child and Adolescent Psychopharmacology, 32, pp. 349 - 357,
    Journal articles | 2022
    Daniels B; Schaffer A; Buckley NA; Bruno C; Jun M; Pearson SA; Zoega H, 2022, 'The impact of tightened prescribing restrictions on proton pump inhibitor use in Australia: An evaluation using interrupted time series analysis', Pharmacoepidemiology and Drug Safety, 31, pp. 370 - 378,
    Journal articles | 2022
    Schaffer AL; Bruno C; Buckley NA; Cairns R; Litchfield M; Paget S; Zoega H; Nassar N; Pearson SA, 2022, 'Prescribed medicine use and extent of off-label use according to age in a nationwide sample of Australian children', Paediatric and Perinatal Epidemiology, 36, pp. 726 - 737,
    Journal articles | 2021
    Daniels B; Healey P; Bruno C; Kaan I; Zoega H, 2021, 'Medicine treatment of glaucoma in Australia 2012-2019: Prevalence, incidence and persistence', BMJ Open Ophthalmology, 6, pp. e000921,
    Journal articles | 2021
    Daniels B; Pearson SA; Buckley NA; Bruno C; Schaffer A; Zoega H, 2021, 'Coming to grips with seemingly conflicting results in programme evaluation: The devil's in the detail', BMJ Quality and Safety, 30, pp. 70 - 71,
    Journal articles | 2021
    De Oliveira Costa J; Bruno C; Schaffer AL; Raichand S; Karanges EA; Pearson SA, 2021, 'The changing face of Australian data reforms: Impact on pharmacoepidemiology research', International Journal of Population Data Science, 6, pp. 1418,
    Journal articles | 2021
    Pearson SA; Pratt N; Costa JDO; Zoega H; Laba TL; Etherton-Beer C; Sanfilippo FM; Morgan A; Ellett LK; Bruno C; Kelty E; Ijzerman M; Preen DB; Vajdic CM; Henry D; de Oliveira Costa J, 2021, 'Generating real-world evidence on the quality use, benefits and safety of medicines in australia: History, challenges and a roadmap for the future', International Journal of Environmental Research and Public Health, 18, pp. 13345,
    Journal articles | 2021
    de Oliveira Costa J; Bruno C; Baranwal N; Gisev N; Dobbins TA; Degenhardt L; Pearson SA, 2021, 'Variations in Long-term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000-2019)', British Journal of Clinical Pharmacology, 87, pp. 3706 - 3720,
    Journal articles | 2020
    Bruno C; Pearson SA; Daniels B; Buckley NA; Schaffer A; Zoega H, 2020, 'Passing the acid test? Evaluating the impact of national education initiatives to reduce proton pump inhibitor use in Australia', BMJ Quality and Safety, 29, pp. 365 - 373,
    Journal articles | 2020
    Daniels B; Pearson SA; Buckley NA; Bruno C; Zoega H, 2020, 'Long-term use of proton-pump inhibitors: whole-of-population patterns in Australia 2013–2016', Therapeutic Advances in Gastroenterology, 13,
  • Preprints | 2024
    Zoega H; Falster M; Gillies M; Litchfield M; Camacho X; Bruno C; Daniels B; Donnolley N; Havard A; Schaffer A; Chambers G; Degenhardt L; Dobbins T; Gisev N; Ivers R; Jorm L; Liu B; Vajdic C; Pearson S-A, 2024, The Medicines Intelligence Data Platform: A population-based data resource from New South Wales, Australia,
    Conference Abstracts | 2022
    Bruno C; Havard A; Gillies M; Coghill D; Brett J; Guastella A; Pearson S-A; Zoega H, 2022, 'Patterns of ADHD medicine use: A population-based study among Australian children and adults (2013-2020)', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 31, pp. 71 - 71,
    Conference Abstracts | 2021
    Bruno C; Havard A; Hanly M; Falster K; Nassar N; Edwards B; Guastella A; Pearson S-A; Zoega H, 2021, 'Children's relative age and medicine treatment for attention-deficit/hyperactivity disorder (ADHD) across Australian jurisdictions with different school enrolment policies', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 166 - 167,
    Conference Abstracts | 2021
    Daniels B; Pearson S-A; Bruno C; Buckley N; Schaffer A; Jun M; Zoega H, 2021, 'Evaluating the impact of new prescribing restrictions for publicy-subsidised proton pump inhibitors in Australia: An interrupted time series analysis', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 30, pp. 219 - 220,
    Conference Presentations | 2021
    Schaffer A; Nassar N; Bruno C; Buckley N; Cairns R; Litchfield M; Paget S; Zoega H; Pearson S, 2021, 'Prescribed Medicine Use in a Nationwide Sample of Australian Children: Extent of Off-Label Use', presented at International Conference on Pharmacoepidemiology and Therapeutic Risk Management, Virtual, 23 August 2021 - 25 August 2021
    Conference Abstracts | 2020
    Bruno C; Costa JDO; Raichand S; Pearson S-A, 2020, 'The Australian pharmacoepidemiology research landscape: The more things change the more they stay the same', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 494 - 495,
    Preprints | 2020
    Costa JDO; Bruno C; Baranwal N; Gisev N; Dobbins T; Degenhardt L; Pearson SA, 2020, Variations in Long-Term Opioid Therapy Definitions: A Systematic Review of Observational Studies Using Routinely Collected Data (2000–2019),
    Conference Abstracts | 2020
    Costa JDO; Bruno C; Baranwal N; Pearson S-A, 2020, 'Variations in long-term opioid use definitions in observational research: A systematic review of studies using routinely collected data', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 29, pp. 174 - 174,
    Conference Abstracts | 2019
    Bruno C; Pearson S-A; Daniels B; Buckley N; Zoega H, 2019, 'Proton pump inhibitor (PPI) use in Australia: Evaluating national quality use of medicines initiatives', in PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, WILEY, Vol. 28, pp. 519 - 519,

  • The Gro Harlem Brundtland Visiting Scholarship, Norway,ÌýÌý2024
  • Australian Government Research Training Program Scholarship, 2020-2024
  • Conference scholarship, International Society of Pharmacoepidemiology,Ìý2023 Mid-Year Meeting, Reykjavik, Iceland.
  • D I McCloskey Stage 3 Physiology Prize for the highest average mark in any three Stage 3 Physiology courses by a graduand with a major in Physiology (2016)

Ìý

Prescription Opioids in the Perinatal Period (POPP) Program:Ìý/medicine-health/our-schools/population-health/research/research-programs-projects/prescription-opioids-in-perinatal-period-program